Study of P-glycoprotein Functionality in Epileptic Rats Using PET
Author Information
Author(s): Syvänen Stina, Luurtsema Gert, Molthoff Carla FM, Windhorst Albert D, Huisman Marc C, Lammertsma Adriaan A, Voskuyl Rob A, de Lange Elizabeth C
Primary Institution: Leiden University
Hypothesis
The study aims to investigate changes in P-glycoprotein expression and functionality at the blood-brain barrier after kainate-induced status epilepticus in rats.
Conclusion
P-glycoprotein expression and functionality does not seem to change at an early stage after induction of anticipated pharmacoresistant epilepsy by kainate.
Supporting Evidence
- All data analysis approaches indicated only modest differences in brain distribution of (R)-[11C]verapamil between saline and kainate treated rats.
- Tariquidar treatment resulted in a more than 10-fold increase in the brain-to-plasma concentration ratio.
- P-gp expression was found to be similar for kainate and saline treated rats.
Takeaway
The study looked at how a protein that helps move drugs in the brain works in rats with seizures, and found that it doesn't change much right after the seizures start.
Methodology
The study used (R)-[11C]verapamil PET imaging to assess P-glycoprotein functionality in saline and kainate treated rats, with analysis of brain distribution and expression through immunohistochemistry.
Limitations
The study was limited by the low baseline signal of (R)-[11C]verapamil and the inability to detect regional differences in P-glycoprotein expression.
Participant Demographics
Adult male Sprague-Dawley rats, weighing 200-224 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website